Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Positive opinion for Allergan's NDO treatment

A positive opinion is given from the Irish Medicines Board for BOTOX treatment for neurogenic detrusor overactivity (NDO). ... Allergan's BOTOX has received a positive opinion from the Irish Medicines Board, for the use of BOTOX for the management of

Allergan and Cephalon breach ABPI code

Allergan was found to be in breach of clauses 2, 9.1 and 25 after Merz Pharma alleged that during a presentation, Allergan implied that its Botox/Vistabel was more potent

Botox approved for chronic migraine

The Botox group also had a greater reduction in total hours of headache. ... In addition, Allergan markets the product as Botox Cosmetic for the improvement of facial lines.

Allergan in $600m Botox settlement

Allergan has agreed to pay $600m as part of a settlement over the company's US marketing practices related to Botox. ... The multi-year investigation that is resolved by the government settlement concerned Allergan's marketing of Botox between 2000 and

Xeomin receives FDA approval

Active comparator studies conducted in Europe, which evaluated Xeomin versus Botox (onabotulinumtoxinA), were also included in the data submitted in support of the registration filing in these conditions.

[ Previous 5 results ] 12 13 14 15 16 17 18 19 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...
Understanding the evolving CAR-T market
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in...

Infographics